Placenta Growth Factor in Eyes with Neovascular Glaucoma Is Decreased after Intravitreal Ranibizumab Injection

about

Intra-individual variability and circadian rhythm of vascular endothelial growth factors in subjects with normal glucose tolerance and type 2 diabetes.

P2860

Q42708389-8CC6A455-7B7E-4C98-BD77-4B918467E4F6

P2860

Placenta Growth Factor in Eyes with Neovascular Glaucoma Is Decreased after Intravitreal Ranibizumab Injection

Item

http://www.wikidata.org/entity/Q35897929

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Placenta Growth Factor in Eyes ...... avitreal Ranibizumab Injection

@ast

Placenta Growth Factor in Eyes ...... avitreal Ranibizumab Injection

@en

type

Item

label

Placenta Growth Factor in Eyes ...... avitreal Ranibizumab Injection

@ast

Placenta Growth Factor in Eyes ...... avitreal Ranibizumab Injection

@en

prefLabel

Placenta Growth Factor in Eyes ...... avitreal Ranibizumab Injection

@ast

Placenta Growth Factor in Eyes ...... avitreal Ranibizumab Injection

@en

P1476

Placenta Growth Factor in Eyes ...... avitreal Ranibizumab Injection

@en

P2093

Jiawei Wang

http://www.w3.org/2001/XMLSchema#string

Minwen Zhou

http://www.w3.org/2001/XMLSchema#string

Wei Wang

http://www.w3.org/2001/XMLSchema#string

Wenbin Huang

http://www.w3.org/2001/XMLSchema#string

Xiaoyan Ding

http://www.w3.org/2001/XMLSchema#string

Xiulan Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension

HIF-1: mediator of physiological and pathophysiological responses to hypoxia

Placental growth factor contributes to micro-vascular abnormalization and blood-retinal barrier breakdown in diabetic retinopathy

Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization.

The discovery of placenta growth factor and its biological activity.

Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets?

Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.

Vascular endothelial growth factor-dependent spatiotemporal dual roles of placental growth factor in modulation of angiogenesis and tumor growth.

Ranibizumab in diabetic macular edema

VEGF/VEGFR pathway inhibitors as anti-angiogenic agents: present and future.

P304

e0146993

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0146993

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

291328572

http://www.w3.org/2001/XMLSchema#string

P698

26785251

http://www.w3.org/2001/XMLSchema#string

P932

4718677

http://www.w3.org/2001/XMLSchema#string

Placenta Growth Factor in Eyes with Neovascular Glaucoma Is Decreased after Intravitreal Ranibizumab Injection

about

P2860

P2860

Placenta Growth Factor in Eyes with Neovascular Glaucoma Is Decreased after Intravitreal Ranibizumab Injection

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932